Table 1.
Demographic characteristics of patients with peripheral neuropathy and CA, and the cardiovascular risk of people with type 2 diabetes mellitus with Charcot arthropathy and people with and without peripheral neuropathy
| Variables | Charcot Arthropathy | Peripheral Neuropathy | Without Peripheral Neuropathy | P Value | |
|---|---|---|---|---|---|
| Age (mean ± SD) | 61.9 ± 7.58 | 60.58 ± 8.16 | 57.88 ± 6.6 | 0.2589 a | |
| Time of diagnosis of diabetes mellitus (mean ± SD) | 18.19 ± 6.77 | 15.67 ± 5.93 | 12.08 ± 10.03 | 0.0420 a | |
| HbA1c (mean ± SD) | 8.83 ± 2.25 | 9.08 ± 1.65 | 8.43 ± 1.84 | 0.5177 a | |
| Sex (n, %) | Male | 13 (61.9%) | 16 (66.67%) | 9 (37.5%) | 0.0956b |
| Female | 8 (38.1%) | 8 (33.33%) | 15 (62.5%) | ||
| High blood pressure (n, %) | 17 (81%) | 18 (75%) | 17 (70.8%) | 0.7334b | |
| Smoking (n, %) | 6 (28.57%) | 8 (33.33%) | 4 (16.67%) | 0.4014b | |
| Dyslipidemia (n,%) | 14 (66.67%) | 8 (33.33%) | 5 (20.8%) | 0.0055b | |
| Symptom score (mean ± SD) | 4.95 ± 3.17 | 4.54 ± 1.79 | 0.71 ± 1.37 | < 0.0001 a | |
| Sign score (mean ± SD) | 8.52 ± 1.69 | 6.79 ± 2.25 | 1.04 ± 1.71 | < 0.0001 a | |
| UKPDS risk | Intermediate | 3 (14.3%) | 4 (16.7%) | 11 (45.8%) | 0.625b |
| High | 9 (42.9%) | 13 (54.2%) | 9 (37.5%) | ||
| Very high | 9 (42.9%) | 7 (29.2%) | 4 (16.7%) | ||
SD (standard deviation); HbA1c (glycated hemoglobin); UKPDS Risk: assessment of cardiovascular risk according to a calculator. a: based on the Kruskal–Wallis test, followed by Dunn's test to determine differences. b: based on the chi-square test